CSL to expand, create 333 jobs

Australia's CSL is getting a boost from the Victorian government, which is backing the company's expansion of its Broadmeadows facility--a move that will create 333 new jobs by 2018, according to a statement.   The facility currently develops vaccines, but the investment focus on supporting new research into cancer, blood disorders, inflammation, infection and developing drugs for clinical trials, The Age reports. CSL's investment will include enhancements to the site to support the...

Eli Lilly backs $250M biotech fund for Asia-Pacific

Eli Lilly (NYSE: LLY) has agreed to chip in $50 million toward a new $250 million biotech venture fund for the Asia-Pacific region that will operate out of Brisbane, Australia. The Queensland government is putting in $25 million in an effort to help spur the biotech industry in the Australian state. Other U.S. pharma companies are reportedly adding their backing to the fund, but only Lilly was named in news reports. And Premier Anna Bligh outlined some starry projections, forecasting that the...